Aptevo Net Cash Flow from Operations from 2010 to 2024
| APVO Stock | USD 0.68 0.06 8.11% |
Check Aptevo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptevo main balance sheet or income statement drivers, such as Depreciation And Amortization of 595.4 K, Interest Expense of 43.1 M or Selling General Administrative of 19.2 M, as well as many exotic indicators such as Price To Sales Ratio of 4.15, Dividend Yield of 3.0E-4 or PTB Ratio of 0.17. Aptevo financial statements analysis is a perfect complement when working with Aptevo Therapeutics Valuation or Volatility modules.
Aptevo | Net Cash Flow from Operations |
About Aptevo Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Aptevo Therapeutics income statement, its balance sheet, and the statement of cash flows. Aptevo Therapeutics investors use historical funamental indicators, such as Aptevo Therapeutics's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Aptevo Therapeutics investors may use each financial statement separately, they are all related. The changes in Aptevo Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aptevo Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aptevo Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aptevo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. Aptevo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
Pair Trading with Aptevo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptevo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Aptevo Stock
| 0.78 | ELYM | Eliem Therapeutics | PairCorr |
| 0.77 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.72 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.7 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.69 | CGC | Canopy Growth Corp Trending | PairCorr |
The ability to find closely correlated positions to Aptevo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptevo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptevo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptevo Therapeutics to buy it.
The correlation of Aptevo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptevo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptevo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptevo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Aptevo Therapeutics Correlation against competitors. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Aptevo Stock analysis
When running Aptevo Therapeutics' price analysis, check to measure Aptevo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptevo Therapeutics is operating at the current time. Most of Aptevo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aptevo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptevo Therapeutics' price. Additionally, you may evaluate how the addition of Aptevo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Aptevo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (67.07) | Quarterly Revenue Growth (1.00) | Return On Assets (0.61) | Return On Equity (1.24) |
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.